On the occasion of the CEATEC Japan 2020 virtual exhibition, Switzerland put the spotlight on the exceptional performance of the Swiss innovation ecosystem with the swisstech.Pitchinar 2020 organized by the Embassy of Switzerland in Japan.
A startup founded at the University of Tokyo has moved a step closer to developing flying cars by teaming with an aircraft component maker.
The startup, which is aiming to commercialize a single-passenger vehicle that flies with propellers, has formed a capital and business partnership with Yoshimasu Seisakusho, a Tokyo-based producer of aircraft engine parts.
Yoshimasu will invest 50 million yen ($470,000) into teTra and help the startup build titanium and aluminum components that need to withstand high temperatures.
A Japanese artificial intelligence startup that had its IPO last week has exceeded $1 billion in market capitalization, even though it has yet to build a solid earnings track record, in a sign that shows an overheating stock market.
Japanese startup ispace has launched a data service aimed at helping companies pursue business opportunities on the moon, part of the lunar rover developer's aim to become a "gateway" for commercial space activities.
Japan's MUFG Bank will use artificial intelligence to screen Asian startups for financing, looking beyond balance sheets to forge relationships with promising businesses who otherwise may not yet qualify for bank loans.
What is the future of batteries? From smartphones to drones to electric cars, the current source of energy is the lithium-ion battery. But startups in Japan are battling to create high-performance power packs that could become the next global standard.
Preferred Networks, a Japanese artificial intelligence startup, is looking for new lines of business. Although the company enjoys backing from a number of big names in Japan, its latest move is motivated by its founder's growing unease over how long it is taking to develop practical uses for its technology.
Drugmakers from Japan, the U.S. and Europe have announced a more than $1 billion fund to invest in startups developing treatments for antibiotic-resistant infections.